Hypertension Drug Market : Revenue, Industry Forecast, User types and Segments order around Industry manufacturers such as Actelion Ltd. Novartis AG Pfizer Inc. Johnson &Johnson Ltd. Sanofi SA Lupin Limited Merck & Co. AstraZeneca plc. Gilead Sciences Inc

According to the Centers of Disease Control and Prevention (CDC), hypertension was the primary reason for death of more than 410,000 Americans in 2014. Hypertension is a long-term disease, and thus requires daily administration of antihypertensive drugs, which is anticipated to drive the hypertension drug market.

Hypertension is a condition where the systolic blood pressure rises over 140 mmHg and diastolic blood pressure over 90 mmHg. The precise cause of hypertension is unknown; however, factors such as smoking, obesity, stress, excess sodium, old age, sleep apnea, certain hormonal conditions, kidney diseases, sedentary lifestyle, poor diet, lack of exercise, and drugs & alcohol contribute to the incidence of hypertension.

Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18):
https://www.alliedmarketresearch.com/checkout/64100?utm_source=Prathm_OPR

Key Benefits:

• The study provides an in-depth analysis of the global Alprazolam powder market, with current trends and future estimations to elucidate the investment pockets.

• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.

• The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.

• Extensive analysis of different segments facilitates to understand various products of the market.

• Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

In addition, R&D activities related to hypertension drugs is expected to present new opportunities during the forecast period. However, patent expiry of antihypertensive drugs, such as Benicar and Diovan, may hinder the market growth. Furthermore, stringent government regulations, adverse effects of these drugs, and high cost of healthcare leading to undiagnosed hypertension restrict the market.

Get sample copy of this report :
www.alliedmarketresearch.com/request-toc-and-sample/2647?utm_source=Prathm_OPR

The market is segmented on the basis of type and geography. Based on type, the market is divided into diuretics, beta blockers, angiotensin-converting enzyme (ACE) inhibitors, alpha-beta blockers, angiotensin II receptor blockers, aldosterone antagonists, calcium channel blockers, renin inhibitors, alpha blockers, central-acting agents, vasodilators, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Top key players :

• Actelion Ltd.
• Novartis AG
• Pfizer Inc.
• Johnson &Johnson Ltd.
• Sanofi SA
• Lupin Limited
• Merck & Co.
• AstraZeneca plc.
• Gilead Sciences Inc.
• GlaxoSmithKline plc

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/2647?utm_source=Prathm_OPR


Table of Content:

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 HYPERTENSION DRUG MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DIURETICS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. BETA BLOCKERS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. ALPHA-BETA BLOCKERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. ANGIOTENSIN II RECEPTOR BLOCKERS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. ALDOSTERONE ANTAGONISTS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

4.8. CALCIUM CHANNEL BLOCKERS

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast

4.9. RENIN INHIBITORS

4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast

4.10. ALPHA BLOCKERS

4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast

4.11. CENTRAL-ACTING AGENTS

4.11.1. Key market trends
4.11.2. Growth factors and opportunities
4.11.3. Market size and forecast

4.12. VASODILATORS

4.12.1. Key market trends
4.12.2. Growth factors and opportunities
4.12.3. Market size and forecast

4.13. OTHERS

4.13.1. Key market trends
4.13.2. Growth factors and opportunities
4.13.3. Market size and forecast

Analyst Reviews:

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology.

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/hypertension-drug-market?utm_source=Prathm_OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.